Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation.

M.M. van Luijn; M.E.D. Chamuleau; G.J. Ossenkoppele; A.A. van de Loosdrecht; S.M. van Ham

doi:10.4161/onci.1.2.18100

Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation.

M.M. van Luijn, M.E.D. Chamuleau, G.J. Ossenkoppele, A.A. van de Loosdrecht, S.M. van Ham

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	211-213
Journal	OncoImmunology
Volume	1
Issue number	2
DOIs	https://doi.org/10.4161/onci.1.2.18100
Publication status	Published - 2012

Access to Document

10.4161/onci.1.2.18100

Cite this

@article{973a6d0e126d45cebca816e0e0b9c6a4,

title = "Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation.",

author = "{van Luijn}, M.M. and M.E.D. Chamuleau and G.J. Ossenkoppele and {van de Loosdrecht}, A.A. and {van Ham}, S.M.",

year = "2012",

doi = "10.4161/onci.1.2.18100",

language = "Undefined/Unknown",

volume = "1",

pages = "211--213",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "Landes Bioscience",

number = "2",

}

Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation. / van Luijn, M.M.; Chamuleau, M.E.D.; Ossenkoppele, G.J.; van de Loosdrecht, A.A.; van Ham, S.M.

In: OncoImmunology, Vol. 1, No. 2, 2012, p. 211-213.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation.

AU - van Luijn, M.M.

AU - Chamuleau, M.E.D.

AU - Ossenkoppele, G.J.

AU - van de Loosdrecht, A.A.

AU - van Ham, S.M.

PY - 2012

Y1 - 2012

U2 - 10.4161/onci.1.2.18100

DO - 10.4161/onci.1.2.18100

M3 - Article

C2 - 22720245

VL - 1

SP - 211

EP - 213

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 2

ER -